Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
150 participants
INTERVENTIONAL
2020-05-07
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell
NCT04710394
Prevalence and Outcomes of Olfactory and Gustatory Dysfunctions in Patients With COVID-19
NCT04524754
Investigating the Efficacy of OMT to Recover Olfactory Perception After COVID-19
NCT06766279
The Efficacy of Modified Olfactory Training for Patients With Olfactory Dysfunction
NCT06353139
The Northern Ireland Sensory Ageing Study
NCT02788695
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
By the beginning of March 2020, several Ear, Nose, Throat societies raised awareness of a frequent association between coronavirus disease 2019 (COVID-19) and smell disorders.
In the present study, the investigators wish to begin to understand the pathogenesis of olfactory dysfunction in COVID-19.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COVID-19 positive or negative patients
Hospitalised patients with or without COVID-19 (with or without olfactory dysfunctions)
Sampling of tissue
In all groups of participants, tissue from the nasal cavity and olfactory system will be surgically removed
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sampling of tissue
In all groups of participants, tissue from the nasal cavity and olfactory system will be surgically removed
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Max Planck Research Unit for Neurogenetics
UNKNOWN
AZ Sint-Lucas Brugge
OTHER
Universitair Ziekenhuis Brussel
OTHER
Hospital Clinic of Barcelona
OTHER
Universitaire Ziekenhuizen KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Laura Van Gerven
Professor doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laura Van Gerven
Role: PRINCIPAL_INVESTIGATOR
UZ/KU Leuven
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UZ Leuven
Leuven, Vlaams-Brabant, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S64042
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.